Drug-induced liver steatosis and phospholipidosis: cell-based assays for early screening of drug candidates.
about
Whole genome transcript profiling of drug induced steatosis in rats reveals a gene signature predictive of outcomeZeGlobalTox: An Innovative Approach to Address Organ Drug Toxicity Using Zebrafish.New pyrazolobenzothiazine derivatives as hepatitis C virus NS5B polymerase palm site I inhibitors.New microRNA Biomarkers for Drug-Induced Steatosis and Their Potential to Predict the Contribution of Drugs to Non-alcoholic Fatty Liver DiseasePsychotropic drugs and liver disease: A critical review of pharmacokinetics and liver toxicity.Transcriptomic signature for drug-induced steatosis.High-content screening technology for studying drug-induced hepatotoxicity in cell models.Long-term microfluidic glucose and lactate monitoring in hepatic cell cultureA metabolomics cell-based approach for anticipating and investigating drug-induced liver injury.Increased hepatic Fatty Acid uptake and esterification contribute to tetracycline-induced steatosis in mice.A simple transcriptomic signature able to predict drug-induced hepatic steatosis.Effect of rosiglitazone on liver structure and function in genetically diabetic Akita mice.Tools to Measure Cell Health and Cytotoxicity Using High Content Imaging and Analysis.A lipidomic cell-based assay for studying drug-induced phospholipidosis and steatosis.A Multi-Parametric Fluorescent Assay for the Screening and Mechanistic Study of Drug-Induced Steatosis in Liver Cells in Culture.LC-MS untargeted metabolomic analysis of drug-induced hepatotoxicity in HepG2 cells.In vitro assessment of drug-induced liver steatosis based on human dermal stem cell-derived hepatic cells.Effect of Toxicants on Fatty Acid Metabolism in HepG2 Cells.Idebenone and coenzyme Q10are novel PPARα/γ ligands, with potential for treatment of fatty liver diseases
P2860
Q28542460-EBDC655C-974F-43B7-A157-F9F480083949Q33624909-D3BD61E4-AD15-47C2-8A51-68A31FFD92C9Q34372464-0A90277B-E394-4269-8029-7EA5078F5C98Q37604102-D8BD1590-0632-4750-8802-E0E252E851A2Q37625519-9A9C17A1-395A-4EFD-80B8-18A5082425FFQ38269300-0E0F6EB4-68D3-4613-9547-BB25E3E38D9AQ38383132-E4E1FE92-28EC-4298-972D-C1619063BAD6Q38985244-728B5991-6B2A-40C1-92A9-09C978A83076Q39707536-B6DD2E96-8086-4176-A002-34D76C25B867Q41283943-DD705546-E9A6-4DE1-984D-FEA2C6169E45Q42707141-CF597A22-2ADB-4FD3-9108-ADD081EB394AQ44973439-8DF7FAB7-D643-4B68-86CB-05CD2819C149Q46272510-D4CCE2E5-AA62-4FDE-A627-D7B6D8D33242Q46364739-7793A8FC-DF05-4911-911B-A26BDFA1A9DDQ46373398-6CD661FC-7458-414F-B040-ABD634303FB9Q50443932-62FF945E-ADF5-4142-B089-18EE1C028FBBQ53603517-55D7624E-4E5D-40AD-8834-1F93CC165569Q55282555-D11EE970-5BC1-4492-BD55-111C8D3CF9C9Q57269164-C64E7724-2A3B-4B04-B11C-A84C00EC5179
P2860
Drug-induced liver steatosis and phospholipidosis: cell-based assays for early screening of drug candidates.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Drug-induced liver steatosis a ...... screening of drug candidates.
@en
type
label
Drug-induced liver steatosis a ...... screening of drug candidates.
@en
prefLabel
Drug-induced liver steatosis a ...... screening of drug candidates.
@en
P1476
Drug-induced liver steatosis a ...... screening of drug candidates.
@en
P2093
M José Gómez-Lechón
M Teresa Donato
P304
P356
10.2174/138920012802850001
P407
P577
2012-10-01T00:00:00Z